Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus

Rheumatology

Volumn 44, Issue 12, 2005, Pages 1564-1568

  Tlacuilo Parra, A ^c,d   Guevara Gutierrez E ^a   Gutierrez Murillo F ^a   Soto Ortiz, A ^a   Barba Gomez F ^a   Hernandez Torres M ^a   Salazar Paramo M ^b  

^a INSTITUTO DERMATOLÓGICO DE JALISCO DR JOSÉ BARBA RUBIO   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d NONE   (Mexico)

Author keywords

Clinical trial; Discoid lupus; Pimecrolimus; Quality of life; Treatment

Indexed keywords

CORTICOSTEROID; PIMECROLIMUS; PLACEBO;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISCOID LUPUS ERYTHEMATOSUS; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; MALE; OPEN STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; SCORING SYSTEM; SKIN BIOPSY; SKIN DISEASE;

ADOLESCENT; ADULT; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; FACIAL DERMATOSES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, DISCOID; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT OUTCOME;

EID: 28544448378     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei093     Document Type: Article

References (29)

1. Callen JP. Discoid lupus erythematosus: Variants and clinical associations. Clin Dermatol 1985;3:49-57.
2. Tebbe B. Clinical course and prognosis of cutaneous lupus erythematosus. Clin Dermatol 2004;22:121-4.
3. Bongu A, Chang E, Ramsey-Goldman R. Can morbidity and mortality of SLE be improved? Best Pract Res Clin Rheumatol 2002;16:313-32.
4. Callen JP. Update on the management of cutaneous lupus erythematosus. Br J Dermatol 2004;151:731-6.
5. Jessop S, Whitelas D, Jordaan F. Drugs for discoid lupus erythematosus (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2002.
6. Fabbri P, Cardinali C, Giomi B, Caproni M. Cutaneous lupus erythematosus: Diagnosis and management. Am J Clin Dermatol 2003;4:449-65.
7. Grassberger M, Steinhoff M, Schneider D, Luger TA. Pimecrolimus an anti-inflammatory drug targeting the skin. Exp Dermatol 2004; 13:721-30.
8. Grassberger M, Baumruker T, Enz A et al. A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: In vitro pharmacology. Br J Dermatol 1999;141:264-73.
9. Wellington K, Jarvis B. Topical pimecrolimus. A review of its clinical potential in the management of atopic dermatitis. Drugs 2002; 62:817-40.
10. Eichenfield LF, Beck L. Elidel (pimecrolimus) cream 1%: A nonsteroidal topical agent for the treatment of atopic dermatitis. J Allergy Clin Immunol 2003;111:1154-68.
11. Harper J, Green A, Scott G et al. First experience of topical SDZ ASM 981 in children with atopic dermatitis. Br J Dermatol 2001; 144:781-7.
12. Walker SL, Kirby B, Chalmers RJG. The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol 2002;147:405-6.
13. Graf J, Webb A, Davis J. The use of topical tacrolimus (FK506/Protopic) in cutaneous manifestations of autoimmune diseases. J Clin Rheumatol 2003;9:310-5.
14. Lampropoulos CE, Sangle S, Harrison P, Hughes GRV, D'Cruz DP. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: A possible alternative. Rheumatology 2004;43:1383-5.
15. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
16. Thivolet J, Nicolas JF, Kanitakis J, Lyonnet S, Chouvet B. Recombinant interferon α2a is effective in the treatment of discoid and subacute cutaneous lupus erythematosus. Br J Dermatol 1990; 122:405-9.
17. Jones-Caballero M, Peñas PF, Garcia-Diez A, Badia X, Chren MM. The Spanish version of skindex-29. Int J Dermatol 2000;39:907-12.
18. Jones-Caballero M, Peñas PF, Garcia-Diez A, Chren MM, Badia X. La versión española de Skindex-29. Un instrumento de medida de la calidad de vida en pacientes con enfermedades cutáneas. Med Clin (Barc) 2002;118:5-9.
19. Queille-Rousell C, Paul C, Duteil L et al. The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: A randomized, double-blind controlled study. Br J Dermatol 2001;144:507-13.
20. Breuer K, Werfel T, Kapp A. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Am J Clin Dermatol 2005;6:65-77.
21. Zabawski E. Treatment of cutaneous lupus with Elidel. Dermatol Online J 2002;8:25.
22. Kreuter A, Gambichler T, Breuckmann F et al. Pimecrolimus 1% cream for cutaneous lupus erythematosus. J Am Acad Dermatol 2004;51:407-10.
23. Boehncke WH, Ochsendorf F, Paeslack I, Kaufmann R, Zollner TM. Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases. Eur J Dermatol 2002; 12:577-80.
24. Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: Meta-analysis of randomized controlled trials. BMJ 2005;330:516-25.
25. Tebbe B, Mazur L, Stadler R, Orfanos CE. Immunohistochemical analysis of chronic discoid and subacute cutaneous lupus erythematosus: Relation to immunopathological mechanisms. Br J Dermatol 1995;132:25-31.
26. Rijlaarsdam JU, Nieboer C, De Vries E, Willemze R. Characterization of the dermal infiltrates in Jessner's lymphocytic infiltrate of the skin, polymorphous light eruption and cutaneous lupus erythematosus: differential diagnostic and pathogenetic aspects. J Cutan Pathol 1990;17:2-8.
27. Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 2002;46:228-41.
28. Kalthhoff FS, Chung J, Stuetz A. Pimecrolimus inhibits upregulation of OX40 and synthesis of inflammatory cytokines upon secondary T cell activation by allogenic dendritic cells. Clin Exp Immunol 2002; 130:85-92.
29. Boguniewicz M, Fiedler VC, Raimer S, Lawrence ID, Leung DYM, Hanifin JM. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. J Allergy Clin Immunol 1998;102:637-44.